{"originalText": "，缘于入院前4月余于我院诊断为直肠癌，于2016-06-22在全麻上行腹腔镜上探查+中转开腹姑息性直肠癌切除+乙状结肠造瘘术。术后病理（201621457），：1、（直肠），：直肠溃疡型黏液腺癌，部分为中分化绒毛状-管状腺癌，侵犯肠壁全层及肠周纤维脂肪组织，未及明确侵犯脉管及神经组织，手术标本双切端均未见癌浸润；找到肠周淋巴结23个均未见癌转移。，免疫组化结果：肿瘤细胞CK20（+），CEA（+），P53（+，野生型），CK7（-），EGFR（+），KI67（40%阳性）。2、（盆壁组织），：送检为增生的纤维及脂肪组织，表面见纤维素样坏死，间质见多量急、慢性炎症细胞浸润。，病理：该病例检测到KRAS基因12号密码子G12D突变。，病理：该病例未检测到BRAF基因V600E突变。术后给予对症、营养支持等治疗，恢复良好，伤口II/甲愈合。2016.07.20、2016.08.10、2016.09.02、2016.09.22、2016.10.14予“奥沙利铂200MGIVGTTD1+卡培他滨1500MGPOBIDD1-14”方案化疗，辅以制酸、保肝、营养支持、增强免疫力等处理。此次为第6次化疗就诊我院，门诊拟直肠癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，造瘘口排便通畅，小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 35, "end_pos": 62}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 82, "end_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 116}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 432, "label_type": "药物", "overlap": 0, "start_pos": 428}, {"end_pos": 449, "label_type": "药物", "overlap": 0, "start_pos": 445}, {"end_pos": 478, "label_type": "解剖部位", "overlap": 0, "start_pos": 477}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 509, "end_pos": 514}, {"end_pos": 536, "label_type": "解剖部位", "overlap": 0, "start_pos": 535}, {"end_pos": 539, "label_type": "解剖部位", "overlap": 0, "start_pos": 538}]}
